Oh goody: A study in Israel says that even a FOURTH SHOT of the coronavirus vaccine might not be enough
· · Jan 18, 2022 · NottheBee.com

Israel was once hailed as the great global coronavirus vaccine success story, an example of how a country could beat COVID by administering just a couple of shots into peoples' arms.

These days they're already talking about shot #5:

Nearly a month after Sheba Medical Center launched a landmark study to test the efficacy of a fourth COVID shot, the hospital said Monday that this fourth booster was only partially effective in protecting against the Omicron strain.

"The vaccine, which was very effective against the previous strains, is less effective against the Omicron strain," Prof. Gili Regev-Yochay, a lead researcher in the experiment said.

"We see an increase in antibodies, higher than after the third dose," Regev-Yochay said. "However, we see many infected with Omicron who received the fourth dose. Granted, a bit less than in the control group, but still a lot of infections," she added.

Are you getting the feeling that... well...

I mean right? Aren't we all sort of silently accepting at this point that the COVID vaccines are now meant to become just a permanent part of our lives? A booster every six months, or four months, or two months, or whenever they say?

The sheer chaotic implementation of it all is bad enough. The accompanying policies of vaccine mandates, vaccine passports, the high moral grandstanding, the hysteria and fear and paranoia—all over a medical injection that, it seems increasingly obvious, doesn't work as originally advertised:

Well, frankly, it's a little unsettling and depressing and I'm not sure how we got here and I'm not sure how we get out of it either.

I think I'll personally pass on the Israel protocol, though!


Comments

There are 49 comments on this article.

Ready to join the conversation? Start your free trial today.

Access comments and our fully-featured social platform, completely free of charge.

Sign up Now
App screenshot

You must signup or login to view or post comments on this article.